全脑放疗同步或序贯替尼泊甙、顺铂治疗小细胞肺癌脑转移(英文)

来源 :Chinese-German Journal of Clinical Oncology | 被引量 : 0次 | 上传用户:zxlpku
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: The aim of the study was to compare efficacies and safeties of 2 different treatments of whole brain radiotherapy (WBRT) sequential or concomitant Vm26/DDP for small cell lung cancer (SCLC) patients with brain metastases. Methods: A total of 39 patients were randomly divided into sequential chemoradiotherapy regime (A group, 20 patients) and concomitant chemoradiotherapy regime (B group, 19 patients). The dose of WBRT was 36 Gy in 18–20 fractions, chemotherapy of Vm26/DDP regimen with teniposide 60 mg/m2 on d1 to d3 and cisplatin 20 mg/m2 on d1 to d5, repeating every 3 weeks. The response was evaluated after WBRT and 2 cycles of chemotherapy. Results: Total response rates of A and B groups were 70.0% and 78.9% respectively (P = 0.520). The median survival was 11 months in A group and 10 months in B group. Six, twelve and eighteen months cumulative survival rates of A and B groups were 75.0%, 42.5%, 26.2%, and 81.6%, 26.4%, 10.5%, respectively (χ2 = 0.383, P > 0.05). Response rate and the number of brain metastases were independent prognostic factors. Conclusion: Both sequential and concomitant chemoradiotherapy groups are effective, and the main toxicity with myelosuppression is tolerable after therapy. It can be applied firstly and effectively to the SCLC patients with brain metastases in clinic . Objective: The aim of the study was to compare efficacies and safeties of 2 different treatments of whole brain radiotherapy (WBRT) sequential or concomitant Vm26 / DDP for small cell lung cancer (SCLC) patients with brain metastases. Methods: A total of 39 patients The dose of WBRT was 36 Gy in 18-20 fractions, chemotherapy of Vm26 / DDP regimen with teniposide 60 mg / m2 on d1 to d3 and cisplatin 20 mg / m2 on d1 to d5, repeating every 3 weeks. The response was evaluated after WBRT and 2 cycles of chemotherapy. Results: Total response rates of A and B groups were 70.0% and 78.9% respectively (P = 0.520). The median survival was 11 months in A group and 10 months in B group. Six, twelve and eighteen months cumulative survival rates of A and B groups were 75.0%, 42.5%, 26.2%, and 81.6% 26.4%, 10.5%, respectively (χ2 = 0.383, P> 0.05) .Respo nse rate and the number of brain metastases were independent prognostic factors. Conclusion: Both sequential and concomitant chemoradiotherapy groups are effective, and the main toxicity with myelosuppression is tolerable after therapy. It can be applied first and effectively to the SCLC patients with brain metastases in clinic.
其他文献
呼吸道合胞病毒(RSV)下呼吸道感染是婴幼儿发病较高、危害较大的一种呼吸系统疾病。其发病机制尚未完全明了.尚无特效防治措施,发病率高,重复感染常见,易继发反复咳喘、气道高反应性疾
如何做到提高物理课堂教学质量,有效的利用各种教学条件及教学资源,充分发挥学生的主体作用和教师的主导作用以及师生之间的配合作用,做到传授知识与培养能力的有机结合,促进
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.
通过对721例肝癌切除术患者的临床资料进行回顾性分析,发现肝癌患者合并门脉性肝硬变者高达883%,术后继发出血率(包括腹腔及消化道出血)为1165%,且术后继发性出血与患者的肝功能状态及是否
下边的当一,上边的当五,一盘小小算珠,把世界算了个清清楚楚。哪家贪赃枉法,哪家洁白清苦,俺叫你心中有个数。三下五去二,二一添作五,天有几多风云,人有几多祸福,君知否?这
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.
期刊
56例嗜铬细胞瘤的护理白求恩医科大学第一临床学院(长春130021)王立波我科从1962年到现在共收治56例嗜铬细胞瘤病人,本文仅就护理体会报告如下。1临床资料本组男性20例,女性36例,年龄最小13岁,最大59岁,男
自从计算机普及以来,“无纸办公”就成为一种美妙的预言,整天聒噪纠缠在我们的耳廓眼底。仿佛只要织造一张大“网”,再稍稍努上一把子力,满世界纸片飞飞的文牍就会消失,对环境危害
【正】 最近,我们对南通市中医中药挖掘、保护和发展问题进行了视察调查。我们感到,中医中药事业在改革开放以来,有了很快发展,成绩是喜人的,但也存在不少问题,令人担忧,亟待